title: [Repeated yearly BCG treatment in superficial bladder cancer].
abstract: The authors report on experiences of treatment for superficial bladder cancer with BCG have achieved during three years. To achieve a permanent recidive prophylaxis the 6 weeks long course was repeated yearly. During the 37-12 months follow up a tumor recurrence have been observed in 10 of 49 patients (20.4%). There have not been seen any serious side-effects requering the interruption of the course or requering any antituberculotica. On the basis of their results and the torelable side-effects they recommend the local BCG treatment as a favourable possibility in prevention of bladder tumor recurrence.
authors.forename: L
authors.initials: L
authors.lastname: Somogyi
authors.forename: A
authors.initials: A
authors.lastname: Török
authors.forename: G
authors.initials: G
authors.lastname: Bors
authors.forename: M
authors.initials: M
authors.lastname: Drinóczy
authors.forename: R
authors.initials: R
authors.lastname: Horváth
mesh_terms: D001500:BCG Vaccine / Q000627:therapeutic use*; D002277:Carcinoma / Q000276:immunology / Q000473:pathology / Q000628:therapy; D005260:Female; D007167:Immunotherapy; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000276:immunology / Q000517:prevention & control / Q000628:therapy; D009367:Neoplasm Staging; D010212:Papilloma / Q000276:immunology / Q000473:pathology / Q000628:therapy; D014374:Tuberculin Test; D001749:Urinary Bladder Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*
chemical_list: D001500:BCG Vaccine
vernacular_title: Felületes hólyagdaganatok évenként ismételt BCG kezelése.